Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia

Bone Marrow Transplantation

Volumn 25, Issue 7, 2000, Pages 717-722

  Pavletic, Z S ^a,c   Arrowsmith, E R ^b   Bierman, P J ^a   Goodman, S A ^b   Vose, J M ^a   Tarantolo, S R ^a   Stein, R S ^b   Bociek, G ^a   Greer, J P ^b   Wu, C D ^a   Kollath, J P ^a   Weisenburger, D D ^a   Kessinger, A ^a   Wolff, S N ^b   Armitage, J O ^a   Bishop, M R ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

B cell; Chronic leukemia; Hematopoietic stem cell transplantation

Indexed keywords

CYCLOSPORIN; FLUDARABINE; FOLIC ACID ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PURINE ANTAGONIST;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; B CELL LEUKEMIA; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LEUKEMIA REMISSION; MALE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION;

EID: 19244373520     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702237     Document Type: Article

References (27)

1. Rozman C, Montserrat E. Chronic lymphocytic leukemia. New Engl J Med 1995; 333: 1052-1057.
2. Keating MJ, O'Brien S, Kantarjian H et al. Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent. Blood 1993; 81: 2878-2884.
3. Montserrat E, Gomis F, Vallespi T et al. Presenting features and prognosis of chronic lymphocytic leukemia in younger adults. Blood 1991; 78: 1545-1551.
4. Pavletic ZS, Bierman PJ, Vose JM et al. High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma. Ann Oncol 1998; 9: 1023-1026.
5. Khouri IF, Keating MJ, Vriesendorp HM et al. Autologous and allogeneic hone marrow transplantation for chronic lymphocytic leukemia: preliminary results. J Clin Oncol 1994; 12: 748-758.
6. Khouri IF. Reading C, Vriesendorp HM et al. High-dose cyclophosphamide, total body irradiation and autologous bone marrow transplantation for chronic lymphocytic leukemia. In: Dicke KA, Keating A (eds). Autologous Marrow and Blood Transplantation, Proceedings of the Seventh International Symposium. The Cancer Treatment Research Center and Educational Institute: Arlington, 1995. pp 219-227.
7. Armitage JO. Bone marrow transplantation. New Engl J Med 1994; 330: 827-838.
8. Rabinowe SN, Soiffer RJ. Gribben JG et al. Autologous and allogeneic hone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1366-1376.
9. Michallet M, Archimbaud E, Bandini G et al. HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. Ann Intern Med 1996; 124: 311-315.
10. Esteve J, Villamor N, Colomer D et al. Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: a report of 12 patients from a single institution. Ann Oncol 1998; 9: 167-172.
11. Martinez, C, Martino R, Brunet S et al. Allogeneic stem cell transplantation for advanced low-grade lymphoproliferative disorders: report of six cases. Hematologica 1996; 81: 330-334.
12. Khouri IF, Przepiorka D, van Besien K et al. Allogeneic blood or marrow transplantation for chronic lymphocytic leukemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease. Br J Haematol 1997; 97: 466-473.
13. Bierman PJ, Warkentin P, Hutchins MR, Klassen LW. Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: response to antithymocyte globulin. Leuk Lymphoma 1993; 9: 169-171.
14. Cheson BD, Bennett JM, Grever M et al. Guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment: NCI-sponsored working group. Blood 1996; 87: 4990-4997.
15. Pavletic ZS, Bishop MR, Tarantolo SR et al. Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. J Clin Oncol 1997; 15: 1608-1616.
16. Stein RS, Greer JP. Goodman S et al. High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin. Bone Marrow Transplant 1999; 23: 227-233.
17. Suttorp M, Schmitz N, Dreger P et al. Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms. Leukemia 1993; 7: 679-687.
18. Sullivan KM. Graft-versus-host disease. In: Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific: Boston, MA, 1994, pp 339-362.
19. Thomas ED, Lochte HL, Lu WC et al. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. New Engl J Med 1957; 157: 491-496.
20. Mehta J, Powles R, Sinhgal S et al. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia. Bone Marrow Transplant 1996: 17: 371-375.
21. Rondon G, Giralt S, Huh Y et al. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia. Bone Marrow Transplant 1996; 18: 669-672.
22. Jarque I, Palau J, Sanz GF et al. Delayed complete response after allogeneic bone marrow transplantation in chronic lymphocytic leukemia (letter). Blood 1993; 82: 1035-1038.
23. Keating MJ, O'Brien S, Lerner S et al. Treatment of chronic lymphocytic leukemia after failure or relapse on fludarabine regimens. Blood 1996; 88: 588a (Abstr.).
24. van Besien K, Sobocinski KA, Rowlings PA et al. Allogeneic bone marrow transplantation for low-grade lymphoma. Blood 1998; 92: 1832-1836.
25. Khouri IF, Keating MK, Korbling M et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment of lymphoid malignancies. J Clin Oncol 1998; 16: 2817-2824.
26. McSweeney PA, Wagner JL, Maloney DG et al. Outpatient PBSC allografts using immunosuppression with low-dose TBI before and cyclosporine and mycophenolate mofetil after transplant. Blood 1998; 92: 518a (Abstr.).
27. Gribben JG, Neuberg D, Soiffer RJ et al. Autologous versus allogeneic bone marrow transplantation for patients with poor prognosis CLL. Blood 1998; 92: 322a (Abstr.).